Systematic Review of Myopia Progression after Cessation of Optical Interventions for Myopia Control
- PMID: 38202060
- PMCID: PMC10779574
- DOI: 10.3390/jcm13010053
Systematic Review of Myopia Progression after Cessation of Optical Interventions for Myopia Control
Abstract
Despite high discontinuation rates for myopia optical interventions, limited attention has been given to the potential rebound effects post-discontinuation. This systematic review aims to assess the extent of the rebound effects following the cessation of common clinical optical myopia-control interventions in children. A comprehensive search of PubMed, Embase, Cochrane CENTRAL, and ClinicalTrials.gov was conducted from inception to October 2023. The rebound effects, defined as changes in the axial length or spherical equivalent during and after treatment cessation, were categorized into four levels. These studies encompassed 703 participants and spanned from 2019 to 2023, with durations of treatment and cessation ranging from 6 months to 3.5 years and from 2 weeks to 5 years, respectively. This review, encompassing 14 studies, revealed a predominant strong rebound effect in orthokeratology (8 studies), a weak rebound effect in multifocal soft contact lenses (4 studies), and a variable rebound effect in peripheral-plus spectacle lenses (2 studies). Notably, with the increasing cessation duration, the rebound effects diminished, potentially linked to the reversal of choroidal thickening and the disappearance of peripheral myopic defocus. In conclusion, a temporal trend of rebound effects exists in all three myopia optical interventions, possibly contributing to their myopia control mechanisms.
Keywords: MiSight; bifocal contact lens; discontinuation; myopia; myopia control; optical interventions; orthokeratology; rebound effect; spectacles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Interventions to slow progression of myopia in children.Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4. Cochrane Database Syst Rev. 2020. PMID: 31930781 Free PMC article.
-
Myopia progression after cessation of atropine in children: a systematic review and meta-analysis.Front Pharmacol. 2024 Jan 22;15:1343698. doi: 10.3389/fphar.2024.1343698. eCollection 2024. Front Pharmacol. 2024. PMID: 38318144 Free PMC article.
-
Rebound Effect in the Misight Assessment Study Spain (Mass).Curr Eye Res. 2021 Aug;46(8):1223-1226. doi: 10.1080/02713683.2021.1878227. Epub 2021 Jan 24. Curr Eye Res. 2021. PMID: 33460537
-
Defocus incorporated multiple segments (DIMS) spectacle lenses increase the choroidal thickness: a two-year randomized clinical trial.Eye Vis (Lond). 2023 Sep 15;10(1):39. doi: 10.1186/s40662-023-00356-z. Eye Vis (Lond). 2023. PMID: 37715201 Free PMC article.
-
Interventions to Reduce Myopia Progression in Children.Strabismus. 2017 Mar;25(1):23-32. doi: 10.1080/09273972.2016.1276940. Epub 2017 Feb 6. Strabismus. 2017. PMID: 28166436 Review.
Cited by
-
Childhood Myopia Part II: Treatment Mechanisms, Emerging Options, and Considerations.Invest Ophthalmol Vis Sci. 2025 Jun 5;66(7):7. doi: 10.1167/iovs.66.7.7. Invest Ophthalmol Vis Sci. 2025. PMID: 40471569 Free PMC article. Review.
-
Key strategies to reduce the global burden of myopia: consensus from the international myopia summit.Br J Ophthalmol. 2025 Apr 22;109(5):535-542. doi: 10.1136/bjo-2024-326643. Br J Ophthalmol. 2025. PMID: 39971325 Free PMC article. Review.
-
Eye growth and myopia progression following cessation of myopia control therapy with a dual-focus soft contact lens.Optom Vis Sci. 2025 May 1;102(5):353-358. doi: 10.1097/OPX.0000000000002244. Epub 2025 Mar 24. Optom Vis Sci. 2025. PMID: 40132119 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources